App Store

Google Play

Device Banner Block-copy 894x1036

Astu lugude lõputusse maailma

Loe ja kuula

Goldman Sachs

"Talks at GS" convenes leading thinkers to share insights and ideas shaping the world.

Goldman Sachs Talks

Software engineering is being redefined with AI agents that can autonomously complete complex tasks, says Russell Kaplan, president of Cognition AI. In conversation with Marco Argenti, Chief Information Officer at Goldman Sachs, Kaplan discusses the company's AI software engineer, Devin, the evolution of AI coding tools, and the skills required to thrive in this new paradigm.

This episode was recorded on July 18, 2025.

The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs. 

A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs. 
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Future of Software Engineering: Cognition’s Russell Kaplan

Memorial Sloan Kettering Cancer Center is a world-renowned institution dedicated to cancer care, research, and education. CEO and president Selwyn M. Vickers, MD, FACS, discusses the latest advancements in cancer treatment, including targeted therapies, immunotherapy, and AI. He shares insights on the "golden era” of cancer treatment and the potential for improved patient outcomes.

This episode was recorded on July 30, 2025.

The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs.

A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs. 

© 2025 Goldman Sachs. All rights reserved. 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Memorial Sloan Kettering Cancer Center’s CEO on the Future of Cancer Treatment

What does it take to succeed on the world stage? In this Talks at GS session, Goldman Sachs Chairman and CEO David Solomon joins members of Team USA and the US Olympic and Paralympic Committee— Chuck Aoki, four-time Paralympic medalist for wheelchair rugby; Meghan Duggan, three-time Olympic medalist for ice hockey; and Gene Sykes, chair of the US Olympic and Paralympic Committee, and co-chair of Global Mergers & Acquisitions at Goldman Sachs. 

This session was recorded on June 11, 2025.

The opinions and views expressed herein are as of the date of publication, subject to change without notice, and may not necessarily reflect the institutional views of Goldman Sachs or its affiliates. The material provided is intended for informational purposes only, and does not constitute investment advice, a recommendation from any Goldman Sachs entity to take any particular action, or an offer or solicitation to purchase or sell any securities or financial products. This material may contain forward-looking statements. Past performance is not indicative of future results. Neither Goldman Sachs nor any of its affiliates make any representations or warranties, express or implied, as to the accuracy or completeness of the statements or information contained herein and disclaim any liability whatsoever for reliance on such information for any purpose. Each name of a third-party organization mentioned is the property of the company to which it relates, is used here strictly for informational and identification purposes only and is not used to imply any ownership or license rights between any such company and Goldman Sachs. 

A transcript is provided for convenience and may differ from the original video or audio content. Goldman Sachs is not responsible for any errors in the transcript. This material should not be copied, distributed, published, or reproduced in whole or in part or disclosed by any recipient to any other person without the express written consent of Goldman Sachs. 

© 2025 Goldman Sachs. All rights reserved. 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Inside the Olympics: Resilience and the Road to LA 2028

Seth Klarman, CEO and portfolio manager of The Baupost Group, is known for his unwavering focus on value. In this conversation with Goldman Sachs President and COO John Waldron, Klarman discusses how his philosophy fits into the current market environment, and how his approach to leading Baupost has evolved in his long career as a fund manager. 

This session was recorded on May 27, 2025. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Seth Klarman on finding value and maintaining discipline

Jim VandeHei is the founder of Axios and Politico – two companies that have emerged as household names in a crowded media landscape. He shares his insights on the evolution of the media industry, the importance of quality journalism, and the keys to building successful media businesses in this conversation with Tony Fratto, global head of corporate communications at Goldman Sachs. 

This episode was recorded on April 9, 2025. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Axios’ Jim VandeHei on how to build a modern media company

Nelly Korda is a world number 1 professional golfer and Olympic gold medalist, who has had 19 professional wins since she went pro in 2016. In this Talks at GS with Goldman Sachs chairman and CEO David Solomon, she discusses her journey from a family of athletes to her professional career, the importance of passion, and the mental and physical challenges of playing golf professionally. Nelly also shared her insights on the future of women’s golf and how her evolving technical skills have allowed her to stay on top. 

This episode was recorded on May 12, 2025. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Nelly Korda: The drive behind a world no. 1 golfer

Alnylam Pharmaceuticals has pioneered RNA interference therapeutics, or RNAi. This groundbreaking technology has increased the company’s success rates of bringing medicines through the clinical pipeline—leading to the approval and launch of six new medicines in just six years. Their CEO Dr. Yvonne Greenstreet spoke with Jerry Lee, head of biopharma banking in the global healthcare group, about the applications of Alnylam’s Nobel Prize-winning RNAi technology, her vision for the future of biotech, and the importance of a patient-focused and teamwork-oriented culture. Dr. Greenstreet also discussed her career journey and leadership philosophy —as one of the only women of color leading a major pharmaceutical company.

This episode was recorded on April 23, 2025. 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Alnylam’s Yvonne Greenstreet on RNAi and a ‘golden era’ in biotech

How can big data reveal the drivers of economic opportunity? Raj Chetty, the William A. Ackman Professor of Economics at Harvard University and director of Opportunity Insights, discusses what can be done to foster upward mobility, the factors that impact a child's chances of success, and the innovative solutions being developed to bridge the opportunity gap. He spoke with Goldman Sachs’ Greg Shell, partner and head of the Inclusive Growth strategy within Asset & Wealth Management, in this Talks at GS. 

This Talks was recorded on March 12, 2025. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Harvard’s Raj Chetty on upward mobility in America

From being the first non-founding employee of Skype to co-founding international money transfer platform Wise, Taavet Hinrikus has been at the center of Europe’s technology ecosystem. Today at early-stage VC Plural, he focuses on funding European tech startups and supporting the next generation of founders. He spoke about the impacts of early exits, the importance of backing mission-driven entrepreneurs, and his optimism for Europe’s tech landscape with Clif Marriott, Goldman Sachs co-head of the Technology, Media and Telecommunications Group in EMEA. The conversation was filmed at Goldman Sachs’ Disruptive Technology Symposium in London on March 5, 2025.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Wise Founder Taavet Hinrikus on Europe’s Tech Renaissance

Adena Friedman, Chair and CEO of Nasdaq, has expanded Nasdaq from an exchange operator to a global technology and insights platform. She spoke with Goldman Sachs COO and President John Waldron about how Nasdaq is utilizing AI and cloud technology to drive financial innovation, as well as the company’s vision for making public markets more attractive to companies. 

This episode was recorded on April 7, 2025. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Nasdaq CEO Adena Friedman on the future of public markets

In this episode, Goldman Sachs’ Sharmin Mossavar-Rahmani discusses the latest developments on COVID-19 therapies and vaccines with a group of leading experts. This podcast was recorded as a phone call on April 14, 2020.
Participants include:
Dr. Richard Hatchett, CEO of Coalition for Epidemic Preparedness Innovations
Esther Krofah, Executive Director of FasterCures
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson

Click below to view materials referenced during the podcast:
https://www.goldmansachs.com/insights/talks-at-gs/04-15-2020-an-update-on-covid-19-therapies-and-vaccines-f/presentation.pdf

This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.
Learn more about your ad choices. Visit megaphone.fm/adchoices

An Update on Therapies and Vaccines

Loe ja kuula

Muud podcastid, mis võivad sulle meeldida ...